Literature DB >> 19870105

AMMONIUM CHLORIDE DECALCIFICATION, AS MODIFIED BY CALCIUM INTAKE: THE RELATION BETWEEN GENERALIZED OSTEOPOROSIS AND OSTITIS FIBROSA.

H L Jaffe1, A Bodansky, J P Chandler.   

Abstract

1. In all age groups the effects of ammonium chloride administration were found to be strikingly dependent upon the calcium intake. 2. Dogs receiving an adequate calcium diet and ammonium chloride showed less decalcification than those receiving a low calcium diet with or without ammonium chloride. 3. In the younger groups the added effect of ammonium chloride to calcium-low diet brought out more striking changes than a low calcium diet alone. 4. When the decalcification was less severe-in the oldest dogs on the low calcium diet with or without ammonium chloride, and in the younger dogs on an adequate calcium intake with ammonium chloride -generalized thinning of the bones without marrow fibrosis resulted (osteoporosis). 5. When the decalcification was rapid and severe-in the youngest dogs on low calcium diet, particularly with ammonium chloride- generalized decalcification and secondary marrow fibrosis resulted (ostitis fibrosa). 6. Generalized ostitis fibrosa is a rather inclusive term and may be applied to the histologic picture which results when clinical or experimental decalcification is rapid, and therefore leads to extensive marrow fibrosis. 7. The special underlying causes of the decalcification may incidentally contribute features to modify the generalized osteoporosis or ostitis fibrosa as in rickets and in von Recklinghausen's disease.

Entities:  

Year:  1932        PMID: 19870105      PMCID: PMC2132205          DOI: 10.1084/jem.56.6.823

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE INFLUENCE OF AGE AND OF DURATION OF TREATMENT ON THE PRODUCTION AND REPAIR OF BONE LESIONS IN EXPERIMENTAL HYPERPARATHYROIDISM.

Authors:  H L Jaffe; A Bodansky; J E Blair
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

2.  EXPERIMENTAL FIBROUS OSTEODYSTROPHY (OSTITIS FIBROSA) IN HYPERPARATHYROID DOGS.

Authors:  H L Jaffe; A Bodansky
Journal:  J Exp Med       Date:  1930-10-31       Impact factor: 14.307

3.  PARATHORMONE DOSAGE AND SERUM CALCIUM AND PHOSPHORUS IN EXPERIMENTAL CHRONIC HYPERPARATHYROIDISM LEADING TO OSTITIS FIBROSA.

Authors:  A Bodansky; H L Jaffe
Journal:  J Exp Med       Date:  1931-04-30       Impact factor: 14.307

  3 in total
  8 in total

1.  Bone maturation in the vitamin D, phosphate deficient rat and the response to acid loading.

Authors:  J E Russell; L V Avioli
Journal:  Calcif Tissue Int       Date:  1979-07-03       Impact factor: 4.333

2.  The effect of excessive acid feeding on bone.

Authors:  U S Barzel
Journal:  Calcif Tissue Res       Date:  1969

Review 3.  [Disorders of Ca metabolism in chronic renal insufficiency].

Authors:  E Ritz; H G Sieberth; B Krempien
Journal:  Klin Wochenschr       Date:  1971-12-15

4.  The effect of metabolic acidosis on vitamin D metabolites and bone histology in uremic rats.

Authors:  Y L Chan; E Savdie; R S Mason; S Posen
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

Review 5.  Osteoclastic differentiation and function regulated by old and new pathways.

Authors:  Harry C Blair; Mone Zaidi
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306

6.  Divalent ion metabolism and osteodystrophy in chronic renal failure.

Authors:  C R Kleeman; O Better; S G Massry; M H Maxwell
Journal:  Yale J Biol Med       Date:  1967-08-01

7.  Acidosis is a key regulator of osteoblast ecto-nucleotidase pyrophosphatase/phosphodiesterase 1 (NPP1) expression and activity.

Authors:  Isabel R Orriss; Michelle L Key; Mark O R Hajjawi; José L Millán; Timothy R Arnett
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

8.  Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.

Authors:  Hyo Jin Kim; Eunjeong Kang; Hyunjin Ryu; Miyeun Han; Kyu-Beck Lee; Yong-Soo Kim; Suah Sung; Curie Ahn; Kook-Hwan Oh
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.